Literature DB >> 11468284

Identification of ligand-binding site III on the immunoglobulin-like domain of the granulocyte colony-stimulating factor receptor.

J E Layton1, N E Hall, F Connell, J Venhorst, H R Treutlein.   

Abstract

The granulocyte colony-stimulating factor receptor (G-CSF-R) forms a tetrameric complex with G-CSF containing two ligand and two receptor molecules. The N-terminal Ig-like domain of the G-CSF-R is required for receptor dimerization, but it is not known whether it binds G-CSF or interacts elsewhere in the complex. Alanine scanning mutagenesis was used to show that residues in the Ig-like domain of the G-CSF-R (Phe(75), Gln(87), and Gln(91)) interact with G-CSF. This binding site for G-CSF overlapped with the binding site of a neutralizing anti-G-CSF-R antibody. A model of the Ig-like domain showed that the binding site is very similar to the viral interleukin-6 binding site (site III) on the Ig-like domain of gp130, a related receptor. To further characterize the G-CSF-R complex, exposed and inaccessible regions of monomeric and dimeric ligand-receptor complexes were mapped with monoclonal antibodies. The results showed that the E helix of G-CSF was inaccessible in the dimeric but exposed in the monomeric complex, suggesting that this region binds to the Ig-like domain of the G-CSF-R. In addition, the N terminus of G-CSF was exposed to antibody binding in both complexes. These data establish that the dimerization interface of the complete receptor complex is different from that in the x-ray structure of a partial complex. A model of the tetrameric G-CSF.G-CSF-R complex was prepared, based on the viral interleukin-6.gp130 complex, which explains these and previously published data.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468284     DOI: 10.1074/jbc.M104787200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Recombinant filgrastim (BK0023) pharmacodynamics and pharmacokinetics after single and multiple escalating doses in an equivalence study in healthy men.

Authors:  Andrea F D Di Stefano; Gaia Spinetti; Antonio Rusca; Milko M Radicioni; Luca Loprete; Domenica M G Lamparelli; Jutta Michael Hepp; Davide Crobu; Rodolfo Schrepfer; Giancarlo Tonon
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

2.  Crystallization of a 2:2 complex of granulocyte-colony stimulating factor (GCSF) with the ligand-binding region of the GCSF receptor.

Authors:  Eijiro Honjo; Taro Tamada; Yoshitake Maeda; Takumi Koshiba; Yasuko Matsukura; Tomoyuki Okamoto; Matsujiro Ishibashi; Masao Tokunaga; Ryota Kuroki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-07-30

3.  A topological refactoring design strategy yields highly stable granulopoietic proteins.

Authors:  Julia Skokowa; Birte Hernandez Alvarez; Murray Coles; Malte Ritter; Masoud Nasri; Jérémy Haaf; Narges Aghaallaei; Yun Xu; Perihan Mir; Ann-Christin Krahl; Katherine W Rogers; Kateryna Maksymenko; Baubak Bajoghli; Karl Welte; Andrei N Lupas; Patrick Müller; Mohammad ElGamacy
Journal:  Nat Commun       Date:  2022-05-26       Impact factor: 17.694

4.  Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.

Authors:  Sabine Le Saux; François Rousseau; Fabien Barbier; Elisa Ravon; Linda Grimaud; Yannic Danger; Josy Froger; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex.

Authors:  Taro Tamada; Eijiro Honjo; Yoshitake Maeda; Tomoyuki Okamoto; Matsujiro Ishibashi; Masao Tokunaga; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  Effect of a structurally modified human granulocyte colony stimulating factor, G-CSFa, on leukopenia in mice and monkeys.

Authors:  Yongping Jiang; Wenhong Jiang; Yuchang Qiu; Wei Dai
Journal:  J Hematol Oncol       Date:  2011-06-13       Impact factor: 17.388

7.  Design of novel granulopoietic proteins by topological rescaffolding.

Authors:  Birte Hernandez Alvarez; Julia Skokowa; Murray Coles; Perihan Mir; Masoud Nasri; Kateryna Maksymenko; Laura Weidmann; Katherine W Rogers; Karl Welte; Andrei N Lupas; Patrick Müller; Mohammad ElGamacy
Journal:  PLoS Biol       Date:  2020-12-22       Impact factor: 8.029

Review 8.  Structural biology of shared cytokine receptors.

Authors:  Xinquan Wang; Patrick Lupardus; Sherry L Laporte; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.

Authors:  Amy M Trottier; Lawrence J Druhan; Ira L Kraft; Amanda Lance; Simone Feurstein; Maria Helgeson; Jeremy P Segal; Soma Das; Belinda R Avalos; Lucy A Godley
Journal:  Blood Adv       Date:  2020-10-27

10.  Paralogs of Common Carp Granulocyte Colony-Stimulating Factor (G-CSF) Have Different Functions Regarding Development, Trafficking and Activation of Neutrophils.

Authors:  Fumihiko Katakura; Kohei Nishiya; Annelieke S Wentzel; Erika Hino; Jiro Miyamae; Masaharu Okano; Geert F Wiegertjes; Tadaaki Moritomo
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.